Infectious Diseases News and Research

RSS

Most inmates have had their covid shots — but their guards likely haven’t

When the number of covid-19 cases among inmates in Pennsylvania state prisons last fall topped 1,000 and staff cases hovered in the hundreds, the union representing 11,000 corrections officers began lobbying to get prison staffers to the front of the line for vaccinations.

8 Jul 2021

Enzyme inhibitor boosts immune system to fight MRSA and other dangerous skin infections

In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander Fleming returned to his laboratory after a vacation in 1928 to find a clear zone surrounding a piece of mold that had infiltrated a petri dish full of Staphylococcus aureus (S. aureus), a common skin bacterium he was growing.

8 Jul 2021

Researchers discover how to artificially produce healthy mucus

Many people instinctively associate mucus with something disgusting, but in fact, it has incredibly many valuable functions for our health. It keeps track of our important intestinal flora and feeds the bacteria.

8 Jul 2021

Mathematical modeling helped inform early statewide policies to reduce COVID-19 transmission

Colorado researchers have published new findings in Emerging Infectious Diseases that take a first look at the use of SARS-CoV-2 mathematical modeling to inform early statewide policies enacted to reduce the spread of the Coronavirus pandemic in Colorado.

7 Jul 2021

Children's Hospital Colorado one of seven hospitals driving pediatric asthma research

Children's Hospital Colorado is one of seven pediatric hospitals joining Childhood Asthma in Urban Settings (CAUSE), a clinical research network established by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health.

7 Jul 2021

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.

7 Jul 2021

Chemotherapy destabilizes gut microbiome in cancer patients

New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.

6 Jul 2021

Mutations in the Epsilon variant contribute to SARS-CoV-2 immune evasion

Three mutations in the Epsilon coronavirus spike protein dampen the neutralizing potency of antibodies induced by current vaccines or past COVID infections.

6 Jul 2021

Exposure to beneficial microorganisms is not affected by targeted hygiene or cleaning

The theory that modern society is too clean, leading to defective immune systems in children, should be swept under the carpet, according to a new study by researchers at UCL and the London School of Hygiene & Tropical Medicine.

5 Jul 2021

Individual variation in viral dynamics could underlie inconsistencies in COVID-19 antiviral treatments

Due to variation in viral dynamics between people, improving the experimental design could help develop effective antiviral treatments for COVID-19.

5 Jul 2021

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.

2 Jul 2021

New $1.7 million project to identify potential COVID-19 treatments

CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.

2 Jul 2021

Monash expert can discuss the significance of R number in COVID-19 infections

A Monash University expert is available to discuss the significance of rate of virus speed (R number), and how the delta variant R number differs from other COVID-19 strains.

2 Jul 2021

Vaccines grown in eggs can lead to an off-target antibody response

Over years of studying antibody responses against the flu in the Wilson lab at the University of Chicago, researchers kept coming up with a strange finding: antibodies that seemed to bind not only to the flu virus but to every virus the lab could throw at them.

2 Jul 2021

Anti-malarial drug shows promise in the battle against COVID-19

In the "war" that the world has been fighting against COVID-19, scientists have been scanning their arsenals of previously used drugs in hopes of finding any that can be used to treat the disease.

1 Jul 2021

Study highlights the importance of T cell cross reactivity in stopping severe COVID-19 infections

Researchers at La Jolla Institute for Immunology have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants.

1 Jul 2021

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

In new research from researchers in the USA and Australia peridomestic mammals, which live in and around human habitations, have been investigated to ascertain how SARS-CoV-2 can affect species external to, but in close proximity to, the human population.

1 Jul 2021

Infectious Diseases News and Research

Most inmates have had their covid shots — but their guards likely haven’t

Enzyme inhibitor boosts immune system to fight MRSA and other dangerous skin infections

Researchers discover how to artificially produce healthy mucus

Mathematical modeling helped inform early statewide policies to reduce COVID-19 transmission

Children's Hospital Colorado one of seven hospitals driving pediatric asthma research

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

Chemotherapy destabilizes gut microbiome in cancer patients

Mutations in the Epsilon variant contribute to SARS-CoV-2 immune evasion

Exposure to beneficial microorganisms is not affected by targeted hygiene or cleaning

Individual variation in viral dynamics could underlie inconsistencies in COVID-19 antiviral treatments

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

New $1.7 million project to identify potential COVID-19 treatments

Monash expert can discuss the significance of R number in COVID-19 infections

Vaccines grown in eggs can lead to an off-target antibody response

Anti-malarial drug shows promise in the battle against COVID-19

Study highlights the importance of T cell cross reactivity in stopping severe COVID-19 infections

Could peridomestic mammals act as zoonotic reservoirs for SARS-CoV-2?

People with COVID-19 frequently infect their pets and cats are particularly at risk

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Frequent testing improves the detection of SARS-CoV-2

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News